> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection Revision on Expanded Access Form
- URL: https://www.fdaweb.com/info-collection-revision-on-expanded-access-form/
- Published: 2022-04-27T12:00:00.000Z
- Updated: 2026-09-14T17:42:21.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151692

*Federal Register* notice: FDA has submitted to OMB an information collection revision entitled “Expanded Access to Investigational Drugs for Treatment Use” (OMB Control Number 0910-0814). The agency has proposed revisions to Form FDA-3926, Individual Patient Expanded Access Investigational New Drug Application. For example, it proposes to move from Field 8 to Field 1 the data fields for “Physician Name, Address, and Contact Information.” Additionally, FDA is adding “Race and Ethnicity” as an optional item under the “Clinical Information/Brief Clinical History” field. To view the notice, click [here](https://public-inspection.federalregister.gov/2022-09070.pdf?ref=fdaweb.com).